Replies to post #202986 on Biotech Values

[ggwpq]

Dew, do you still have a long position in AMRN? If yes, I assume you like REDUCE-IT's chances.

[jbog]

Merck has GT1B approval in EU so we'll see what happens. It seems to me that the big buyers don't currently care about 6 week, 8 week or 12 weeks duration nor the dosage type. They want to cure as many as cheaply as possible and get the press off their backs.